AstraZeneca Pharma India Limited has made a disclosure to BSE Limited and National Stock Exchange of India Ltd. regarding an ESG rating assignment. Crisil ESG Ratings & Analytics Limited has assigned the company an Environmental, Social, and Governance (ESG) rating of 64 for fiscal year 2026. The rating was based solely on publicly available information about the company.
The company specifically notes that it did not engage Crisil ESG Ratings for this assessment. The rating agency independently prepared their reporting using publicly available company information. This disclosure is made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The communication was digitally signed by Tanya Sanish, Company Secretary & Compliance Officer of AstraZeneca Pharma India Limited, on September 2, 2026 at 18:10:20 IST.